As shown in Figure 3A, the expression levels of TP53 with activating mutations in the 98 ovarian cancer samples were significantly higher than the expression levels of TP53 in the eight normal controls (p = 0.044, two tailed t-test). The gene discussed is TP53; the disease is ovarian carcinoma.